CJC-1295 (No DAC) + Ipamorelin Blend Pen

Over CJC-1295 (No DAC) + Ipamorelin Blend Pen

This format is offered as a research pen, with 5+5 MG as the stated strength. The pen shape requires its own information about the device and its contents. The amount in milligrams in itself says nothing about the fluid volume, a concentration or the delivery per setting.

Wat is CJC-1295 (No DAC) + Ipamorelin Blend?

This blend combines the peptide presented as CJC-1295 No DAC with ipamorelin. The components are investigated in relation to different routes of growth hormone release.

The addition No DAC is essential when comparing literature. Research into long-acting, albumin-binding CJC-1295 does not directly support this No DAC blend.

What does the research focus on?

The area of ​​research includes pituitary signalling and the comparison of different receptor-dependent pathways. A combination must be assessed as its own research material.

• GHRH-related signalling and the pathway by which ipamorelin is investigated.
• Separate and combined responses in an appropriate research model.
• Checking peptide identity, DAC status and component ratio.

Product specifications

Using this research pen

Use this product only within a validated laboratory workflow and after consulting the manufacturer's current operating instructions. The public product information does not establish fill volume, concentration, dispensing increment, accuracy, sterility, stability or cartridge compatibility.

• Check the selected strength, compound identity and batch before starting the experiment.
• Consult the current operating instructions, safety data sheet and batch documentation.
• Validate device, cartridge and solvent compatibility, as well as dispensing accuracy for the selected method.
• Document preparation, storage, handling, cleaning and disposal within the laboratory workflow.

Do not use instructions written for an authorised medicine pen with this research pen.

Frequently asked questions

Is this the same blend as Tesamorelin + Ipamorelin?

No. The first component is CJC-1295 No DAC and not tesamorelin. The description and specifications of a tesamorelin blend are therefore not interchangeable.

Wat betekent de aanduiding 5+5 MG?

The catalogue lists two component quantities. The available vial report #211784 reports measured content per component and does not provide a purity percentage for the blend.

Is the pen the same format as the vial?

CJC-1295 (No DAC) + Ipamorelin Blend Pen is a separate product format that can share substance documentation with the vial. Device compatibility, retail content and the link to the delivered batch must be assessed separately for the pen.

How should I store this product?

Follow the current storage information for the supplied batch and product format. Do not use a general storage temperature or shelf life from a comparable product as a substitute for its own documentation.

Research references

• Primair onderzoek naar ipamorelin — Raun et al.
• Onderzoek naar albuminebindend CJC-1295 — Jetté et al.

The CJC-1295 article discusses an albumin binding analog and is not proof of this No DAC implementation. The sources also do not certify the combined Novogin blend.

For laboratory and analytical research only. Not for use in humans or animals, consumption, cosmetic use or use as a food supplement. This research material is not offered as an approved medicine. No medical, dosing or injection advice is provided.